We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $17.1B
1-Year Est. Return 70.99%
This Fund
S&P 500
This Quarter Est. Return
+13.9%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
AUM
$10.6B
AUM Growth
+$4.32B
Cap. Flow
+$4.15B
Cap. Flow %
39.25%
Top 10 Hldgs %
26.92%
Holding
1,909
New
683
Increased
298
Reduced
275
Closed
491

Sector Composition

Rank Sector Weight
1 Technology 7.39%
2 Consumer Discretionary 5.98%
3 Communication Services 3.46%
4 Healthcare 1.95%
5 Financials 1.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BA icon
451
CALL
Boeing
BA
$184B
$3.93M 0.04%
22,200
QURE icon
452
CALL
uniQure
QURE
$3.02B
$3.92M 0.04%
222,000
+198,000
+825% +$1.71M
ITOS
453
DELISTED
iTeos Therapeutics
ITOS
$3.92M 0.04%
+509,829
New +$4.38M
MDB icon
454
MongoDB
MDB
$29.1B
$3.91M 0.04%
16,800
GEHC icon
455
CALL
GE HealthCare
GEHC
$31.4B
$3.91M 0.04%
50,000
NCLH icon
456
CALL
Norwegian Cruise Line
NCLH
$8.91B
$3.86M 0.04%
150,000
+50,000
+50% +$1.26M
ARWR icon
457
CALL
Arrowhead Research
ARWR
$11.9B
$3.85M 0.04%
205,000
+180,000
+720% +$3.71M
WBD icon
458
Warner Bros
WBD
$65.8B
$3.85M 0.04%
364,600
-65,400
-15% -$608K
DV icon
459
PUT
DoubleVerify
DV
$1.78B
$3.84M 0.04%
200,000
BBIO icon
460
CALL
BridgeBio Pharma
BBIO
$15.7B
$3.84M 0.04%
140,000
-151,400
-52% -$3.91M
AKAM icon
461
CALL
Akamai
AKAM
$17.1B
$3.83M 0.04%
+40,000
New +$3.92M
RVMD icon
462
CALL
Revolution Medicines
RVMD
$38.8B
$3.82M 0.04%
+87,400
New +$4.41M
PTGX icon
463
Protagonist Therapeutics
PTGX
$8.52B
$3.82M 0.04%
98,934
+76,834
+348% +$3.35M
NKE icon
464
CALL
Nike
NKE
$63.2B
$3.78M 0.04%
50,000
-10,000
-17% -$786K
CEG icon
465
Constellation Energy
CEG
$97.3B
$3.78M 0.04%
16,900
+13,839
+452% +$3.45M
EVH icon
466
CALL
Evolent Health
EVH
$359M
$3.77M 0.04%
335,000
-52,500
-14% -$923K
SSNC icon
467
CALL
SS&C Technologies
SSNC
$18.5B
$3.75M 0.04%
+49,500
New +$3.7M
NXT icon
468
PUT
Nextpower Inc
NXT
$13.9B
$3.74M 0.04%
102,500
+80,000
+356% +$2.93M
XPO icon
469
PUT
XPO
XPO
$23B
$3.72M 0.04%
+28,400
New +$3.84M
NAMS icon
470
NewAmsterdam Pharma
NAMS
$3.18B
$3.72M 0.04%
+144,578
New +$3.07M
TGTX icon
471
CALL
TG Therapeutics
TGTX
$7.08B
$3.71M 0.04%
123,200
+93,200
+311% +$2.67M
W icon
472
Wayfair
W
$11.7B
$3.69M 0.03%
83,267
+2,467
+3% +$116K
ELV icon
473
CALL
Elevance Health
ELV
$82.6B
$3.69M 0.03%
+10,000
New +$4.18M
ELV icon
474
PUT
Elevance Health
ELV
$82.6B
$3.69M 0.03%
+10,000
New +$4.18M
RVLV icon
475
PUT
Revolve Group
RVLV
$1.83B
$3.68M 0.03%
110,000
-25,000
-19% -$774K

Similar funds

Caption Management's Q4 2024 Portfolio in Review

As of Q4 2024, Caption Management held 1,909 positions worth $10.6B, up 69% from $6.27B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Caption Management deployed $4.15B of net new capital in Q4 2024, opening 683 new positions and adding to 298 existing holdings. Its largest new stake was NVIDIA: 4,060,000 shares worth $545M.

By sector, the portfolio is most concentrated in Technology at 7.4% of assets, up from 2% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was State Street SPDR S&P Regional Banking ETF, an estimated $63.1M trimmed.

  • Caption Management's largest Q4 2024 buy was NVIDIA: 4,060,000 shares worth $545M.
  • Caption Management added most to Alphabet (Google) Class C in Q4 2024, an estimated $121M increase.
  • Caption Management's biggest Q4 2024 reduction was State Street SPDR S&P Regional Banking ETF, cutting an estimated $63.1M.
  • Caption Management fully exited Broadcom in Q4 2024, selling an estimated $20.5M.
  • Caption Management's ten largest holdings make up 27% of its $10.6B portfolio in Q4 2024.
  • Caption Management opened 683 new positions and closed 491 in Q4 2024.
  • Caption Management's portfolio value rose 69% quarter-over-quarter to $10.6B.

Based on Caption Management's 13F filing for Q4 2024, filed 14 Feb 2025.